5 Breast Cancer Clinical Trials in Cerritos, CA (2026)

Q: How do I join a clinical trial in Cerritos?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Cerritos research site will contact you.

Recruiting Breast Cancer Studies in Cerritos

NCT05827081Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on in...

Cerritos, CAPHASE31,400 participantsNovartis Pharmaceuticals

View Study Details

NCT05150691Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2....

Cerritos, CAPHASE1796 participantsDualityBio Inc.

View Study Details

NCT06324357Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

This study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People can take part in this study if their tumours show HER...

Cerritos, CAPHASE1768 participantsBoehringer Ingelheim

View Study Details

NCT06435429Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the...

Cerritos, CAPHASE3550 participantsJazz Pharmaceuticals

View Study Details

NCT06926868Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physi...

Cerritos, CAPHASE2500 participantsBristol-Myers Squibb

View Study Details

About Breast Cancer Clinical Trials in Cerritos

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 5 breast cancer clinical trials recruiting participants in Cerritos, CA. These studies are seeking a combined 4,014 participants. Research is being sponsored by Novartis Pharmaceuticals, DualityBio Inc., Boehringer Ingelheim and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Cerritos — FAQ

Are there breast cancer clinical trials in Cerritos?

Yes, there are 5 breast cancer clinical trials currently recruiting in Cerritos, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cerritos?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cerritos research site will contact you about next steps.

Are clinical trials in Cerritos free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cerritos studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 5 active trials in Cerritos are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 22, 2026 from ClinicalTrials.gov